New York, February 26, 2018:

    Meningococcal Vaccines Market 2018

    The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.0 billion by 2022 and will grow at a CAGR of more than 12% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets on Global Meningococcal Vaccines Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, JN-International Medical Corporation, Novartis International AG, GlaxoSmithKline plc, Sanofi S.A. Inc., Serum Institute of India Ltd., Nuron Biotech. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report

    The Global Meningococcal Vaccines Market has been segmented as below:

    By Type Analysis

    •  Polysaccharide Vaccines, by Brand
      Menomune
      Mencevax
      NmVac4
      Others
      Quadri Meningo
      Bi Meningo

      •    Conjugate Vaccines, by Brand
      Menactra
      Menveo
      NeisVac-C
      Nimenrix
      Meningitec
      Menjugate
      MenAfriVac
      NmVac4-DT

      •    Combination Vaccines, by Brand
      MenHibrix
      Menitorix

      •    Men B Vaccines, by Brand
      Bexsero
      Trumenba

      By Regional Analysis
      North America
      Europe
      Asia-Pacific
      Rest of the World

    This report provides:
    1) An overview of the global market for Global Meningococcal Vaccines Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Meningococcal Vaccines Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.
    Ask Sample Report: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report

     

    Table of Contents

    1 INTRODUCTION

    2 Research Methodology

    3 Global Meningococcal Vaccines Market Overview

    4 Global Meningococcal Vaccines Market, by Type

    4.1 Introduction
    4.1.1 Global Meningococcal Vaccines Market Revenue, by Type, 2012 – 2022
    4.2 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2013 & 2022
    4.2.1 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2013 & 2022
    4.3 Polysaccharide Meningococcal Vaccines
    4.3.1 Global Polysaccharide Vaccines Market Revenue, by Brand, 2012 – 2022
    4.3.2 Menomune
    4.3.2.1 Global Menomune Market Revenue, 2012 – 2022
    4.3.3 Mencevax
    4.3.3.1 Global Mencevax Market Revenue, 2012 – 2022
    4.3.4 NmVac4-A/C/Y/W-135
    4.3.4.1 Global NmVac4 Market Revenue, 2012 – 2022
    4.3.5 Others (Bi Meningo, Quadri Meningo)
    4.3.5.1 Global Other Polysaccharide Vaccines Market Revenue, 2012 – 2022
    4.4 Conjugate Meningococcal Vaccines
    4.4.1 Global Conjugate Vaccines Market Revenue, by Brand, 2012 – 2022
    4.4.2 Menactra
    4.4.2.1 Global Menactra Market Revenue, 2012 – 2022
    4.4.3 Menveo
    4.4.3.1 Global Menveo Market Revenue, 2012 – 2022
    4.4.4 NeisVac-C
    4.4.4.1 Global NeisVac-C Market Revenue, 2012 – 2022
    4.4.5 Nimenrix
    4.4.5.1 Global Nimenrix Market Revenue, 2012 – 2022
    4.4.6 Meningitec
    4.4.6.1 Global Meningitec Market Revenue, 2012 – 2022
    4.4.7 Menjugate (Meningococcal Group C- CRM197 Conjugate Vaccine)
    4.4.7.1 Global Menjugate Market Revenue, 2012 – 2022
    4.4.8 MenAfriVac
    4.4.8.1 Global MenAfriVac Market Revenue, 2012 – 2022
    4.4.9 NmVac4-A/C/Y/W-135-DT (Nm-Vac4-DT)
    4.4.9.1 Global NmVac4 DT Market Revenue, 2016 – 2022
    4.5 Combination Meningococcal Vaccines
    4.5.1 Global Combination Vaccines Market Revenue, by Brand, 2012 – 2022
    4.5.2 MenHibrix
    4.5.2.1 Global MenHibrix Market Revenue, 2014 – 2022
    4.5.3 Menitorix
    4.5.3.1 Global Menitorix Market Revenue, 2012 – 2022
    4.6 Meningococcal B Vaccines
    4.6.1 Bexsero
    4.6.1.1 Global Bexsero Market Revenue, 2014 – 2022
    4.6.2 Trumenba (MnB rLP2806)
    4.6.2.1 Global Trumenba Market Revenue, 2015 – 2022

    5 Global Meningococcal Vaccines Market, by Geography

    6 Competitive Landscape

    7 Recommendations

    8 Company Profiles

    8.1 Baxter International, Inc.

    8.2 Biomed Pvt., Ltd.

    8.3 GlaxoSmithKline plc

    8.4 JN-International Medical Corporation

    8.5 Nuron Biotech, Inc.

    8.6 Pfizer, Inc.

    8.7 Sanofi SA

    8.8 Serum Institute of India, Ltd.

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/meningococcal-vaccines-market-2018-industry-analysis-growth-and-forecast-to-2022